Article info

Download PDFPDF
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations
  1. Dr C Cybulski, International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ul. Połabska 4, 70–115 Szczecin, Poland; cezarycy{at}sci.pam.szczecin.pl
View Full Text

Citation

Cybulski C, Górski B, Huzarski T, et al
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations

Publication history

  • Received July 9, 2008
  • Revised August 28, 2008
  • Accepted September 7, 2008
  • First published October 17, 2008.
Online issue publication 
April 27, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.